Sir Peter Karel, Baron Piot is a Belgian-British microbiologist known for his research into Ebola and AIDS.
The Canadian Institutes of Health Research is a federal agency responsible for funding health and medical research in Canada. Comprising 13 institutes, it is the successor to the Medical Research Council of Canada.
GISAID, the Global Initiative on Sharing All Influenza Data, previously the Global Initiative on Sharing Avian Influenza Data, is a global science initiative established in 2008 to provide access to genomic data of influenza viruses. The database was expanded to include the coronavirus responsible for the COVID-19 pandemic, as well as other pathogens. The database has been described as "the world's largest repository of COVID-19 sequences". GISAID facilitates genomic epidemiology and real-time surveillance to monitor the emergence of new COVID-19 viral strains across the planet.
Margaret Ann "Peggy" Hamburg is an American physician and public health administrator, who is serving as the chair of the board of the American Association for the Advancement of Science (AAAS) and co-chair of the InterAcademy Partnership (IAP). She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015.
Tuberculosis in India is a major health problem, causing about 220,000 deaths every year. In 2020, the Indian government made statements to eliminate tuberculosis from the country by 2025 through its National TB Elimination Program. Interventions in this program include major investment in health care, providing supplemental nutrition credit through the Nikshay Poshan Yojana, organizing a national epidemiological survey for tuberculosis, and organizing a national campaign to tie together the Indian government and private health infrastructure for the goal of eliminating the disease.
Sir Jeremy James Farrar is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.
Gagandeep Kang FRS is an Indian microbiologist and virologist who has been leading the work on enteric diseases, diarrheal infections and disease surveillance at the Bill & Melinda Gates Foundation since 2023.
The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).
Francine NtoumiPh.D., HDR, PvDz, FRCPedin is a Congolese parasitologist specializing in malaria. She was the first African person in charge of the secretariat of the Multilateral Initiative on Malaria (2006-2010). In recent years, she has become involved in research on other infectious diseases, including COVID-19.
Linda-Gail Bekker MBChB, DTMH, DCH, FCP(SA) is a Professor of Medicine and Chief Operating Officer of the Desmond Tutu HIV Foundation. She is also Director of the Desmund Tutu HIV Centre at the University of Cape Town. She is a Past President of the International AIDS Society (2016-18).
Anita Kaniz Mehdi Zaidi is a Pakistani physician. She is the President of the Gender Equality Division and Director of Vaccine Development, Global Health Surveillance, Diarrhea and Enteric Diseases at the Bill & Melinda Gates Foundation. She has previously served as Professor of Paediatrics and Child Health at the Aga Khan University.
Richard Hatchett is an American oncologist and epidemiologist who has been serving as chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI) in Oslo and London since 2017. He was awarded the Secretary of Health and Human Services's Award for Distinguished Service.
Patricia Jannet García Funegra is a Peruvian professor of public and global health at Cayetano Heredia University. She originally trained as a clinician before focusing on research and public health. Her work also focuses on reproductive health, sexually transmitted diseases, and medical informatics. In 2016-17 García was the Minister of Health of Peru. She was the first Peruvian to be elected to the US National Academy of Medicine in 2016.
The Access to COVID-19 Tools Accelerator, or the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020. A call to action was published simultaneously by the World Health Organization (WHO) on 24 April. As of January 2022, it was the largest international effort to achieve equitable access to COVID-19 health technologies.
John N. Nkengasong is a Cameroonian-American virologist serving as the Global AIDS Coordinator in the Biden administration since 2022 and Senior Bureau Official for Global Health Security and Diplomacy since 2023. He previously worked as the Director of the Africa Centres for Disease Control and Prevention from 2016 to 2022, as well as at the World Health Organization (WHO) and Centers for Disease Control and Prevention. During the COVID-19 pandemic, Nkengasong was appointed the WHO Special Envoy for Africa.
The Women Leaders in Global Health Conference, created by Michele Barry and first held in 2017 at Stanford University in partnership with Women in Global Health, the US National Institutes of Health and others, is an international conference that engages both men and women to address the gender gap in global health leadership.
Poonam Khetrapal Singh is the first Indian elected Regional Director of WHO’s South-East Asia Region. She was also the first woman in the region to assume the office of WHO Regional Director for South-East Asia in February 2014. In September 2018, she was unanimously elected for a second five-year term by the 71st Regional Committee and 144th Session of the WHO Executive Board.
Madhukar Pai is an Indian medical doctor, academic, advocate, writer, and university professor. He is the Associate Director of the McGill International Tuberculosis Centre. Pai's work focuses on global health, specifically advocacy for better treatment for tuberculosis with a focus on South Africa and India. Pai is the inaugural Chair of the Department of Global and Public Health in the School of Population and Global Health and holds a Canada Research Chair in Epidemiology and Global Health at McGill University.
Gary P. Kobinger is a Canadian immunologist and virologist who is currently the director at the Galveston National Laboratory at the University of Texas. He has held previous professorships at Université Laval, the University of Manitoba, and the University of Pennsylvania. Additionally, he was the chief of the Special Pathogens Unit at the National Microbiology Laboratory (NML) of the Public Health Agency of Canada (PHAC) in Winnipeg, Manitoba, for eight years. Kobinger is known for his critical role in the development of both an effective Ebola vaccine and treatment. His work focuses on the development and evaluation of new vaccine platforms and immunological treatments against emerging and re-emerging viruses that are dangerous to human health.
Kayla F. Laserson is an American epidemiologist serving as the director of the Global Health Center at the Centers for Disease Control and Prevention (CDC) since July 2023. She was previously the deputy director for Infectious Diseases and Vaccine Delivery, India Office of the Bill & Melinda Gates Foundation. Laserson served as a commander in the United States Public Health Service Commissioned Corps until 2007.
